| NCT02202187 | Infections, Respiratory Tract | Phase 1 | Completed | - | United States, Minnesota
... more >>
GSK Investigational Site
Minneapolis, Minnesota, United States, 55404 Collapse << |
| NCT01706315 | Infections, Respiratory Tract | Phase 1 | Completed | - | United States, Kansas
... more >>
GSK Investigational Site
Overland Park, Kansas, United States, 66211 Collapse << |
| NCT02045849 | Infections, Bacterial | Phase 1 | Completed | - | United States, Kansas
... more >>
GSK Investigational Site
Overland Park, Kansas, United States, 66211 Collapse << |
| NCT01934205 | Infections, Bacterial | Phase 1 | Completed | - | United States, Maryland
... more >>
GSK Investigational Site
Baltimore, Maryland, United States, 21225 Collapse << |
| NCT02294682 | Gonorrhea | Phase 2 | Completed | - | United States, California
... more >>
GSK Investigational Site
Fountain Valley, California, United States, 92708
GSK Investigational Site
Los Angeles, California, United States, 90028
GSK Investigational Site
Los Angeles, California, United States, 90069
GSK Investigational Site
Palm Springs, California, United States, 92262
GSK Investigational Site
San Francisco, California, United States, 94103
United States, Florida
GSK Investigational Site
Orlando, Florida, United States, 32806
United States, Georgia
GSK Investigational Site
Atlanta, Georgia, United States, 30308
United States, Indiana
GSK Investigational Site
Indianapolis, Indiana, United States, 46202
United States, Louisiana
GSK Investigational Site
New Orleans, Louisiana, United States, 70119
United States, Nebraska
GSK Investigational Site
Omaha, Nebraska, United States, 68114
United States, Ohio
GSK Investigational Site
Cleveland, Ohio, United States, 44109
United States, Pennsylvania
GSK Investigational Site
Jenkintown, Pennsylvania, United States, 19046
Puerto Rico
GSK Investigational Site
San Juan, Puerto Rico, 00927
United Kingdom
GSK Investigational Site
London, United Kingdom, SW10 9NH Collapse << |
| NCT02045797 | Infections, Bacterial | Phase 2 | Completed | - | - |
| NCT01615796 | Infections, Respiratory Tract | Phase 1 | Completed | - | Australia, New South Wales
... more >>
GSK Investigational Site
Randwick, New South Wales, Australia, 2031 Collapse << |
| NCT02000765 | Infections, Respiratory Tract | Phase 1 | Completed | - | United Kingdom
... more >> GSK Investigational Site
London, United Kingdom, NW10 7NS Collapse << |
| NCT02257398 | Infections, Respiratory Tract | Phase 1 | Completed | - | United States, Texas
... more >>
GSK Investigational Site
Austin, Texas, United States, 78744 Collapse << |
| NCT02045797 | - | - | Completed | - | - |
| NCT02853435 | Infections, Bacterial | Phase 1 | Completed | - | United States, California
... more >>
GSK Investigational Site
Anaheim, California, United States, 92801
United States, Texas
GSK Investigational Site
Austin, Texas, United States, 78744 Collapse << |
| NCT02729038 | Infections, Bacterial | Phase 1 | Completed | - | United States, Florida
... more >>
GSK Investigational Site
Miami, Florida, United States, 33136
GSK Investigational Site
Orlando, Florida, United States, 32809
United States, Minnesota
GSK Investigational Site
Minneapolis, Minnesota, United States, 55404 Collapse << |
| NCT02294682 | - | - | Completed | - | - |
| NCT03562117 | Infections, Bacterial | Phase 1 | Recruiting | April 10, 2019 | United States, Florida
... more >>
GSK Investigational Site
Recruiting
Miami, Florida, United States, 33136
Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com
GSK Investigational Site
Recruiting
Orlando, Florida, United States, 32809
Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse << |
| NCT02729038 | - | - | Completed | - | - |
| NCT03568942 | Infections, Bacterial | Phase 2 | Recruiting | December 14, 2018 | United States, California
... more >>
GSK Investigational Site
Recruiting
La Mesa, California, United States, 91942
Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com
Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com Collapse << |
| NCT02853435 | - | - | Completed | - | - |
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
